Literature DB >> 30963545

Targeted hippocampal GABA neuron ablation by Stable Substance P-saporin causes hippocampal sclerosis and chronic epilepsy in rats.

Eugene Chun1, Argyle V Bumanglag2, Sara N Burke3, Robert S Sloviter2,4,5.   

Abstract

Cryptogenic temporal lobe epilepsy develops in the absence of identified brain injuries, infections, or structural malformations, and in these cases, an unidentified pre-existing abnormality may initiate febrile seizures, hippocampal sclerosis, and epilepsy. Although a role for GABAergic dysfunction in epilepsy is intuitively obvious, no causal relationship has been established. In this study, hippocampal GABA neurons were targeted for selective elimination to determine whether a focal hippocampal GABAergic defect in an otherwise normal brain can initiate cryptogenic temporal lobe epilepsy with hippocampal sclerosis. We used Stable Substance P-saporin conjugate (SSP-saporin) to target rat hippocampal GABA neurons, which selectively and constitutively express the neurokinin-1 receptors that internalize this neurotoxin. Bilateral and longitudinally extensive intrahippocampal microinjections of SSP-saporin caused no obvious behavioral effects for several days. However, starting ~4 days postinjection, rats exhibited episodes of immobilization, abnormal flurries of "wet-dog" shakes, and brief focal motor seizures characterized by facial automatisms and forepaw clonus. These clinically subtle behaviors stopped after ~4 days. Convulsive status epilepticus did not develop, and no deaths occurred. Months later, chronically implanted rats exhibited spontaneous focal motor seizures and extreme hippocampal sclerosis. These data suggest that hippocampal GABAergic dysfunction is epileptogenic and can produce the defining features of cryptogenic temporal lobe epilepsy. Wiley Periodicals, Inc.
© 2019 International League Against Epilepsy.

Entities:  

Keywords:  Stable Substance P-saporin; cryptogenic temporal lobe epilepsy; dentate gyrus; hippocampal sclerosis; hippocampus

Mesh:

Substances:

Year:  2019        PMID: 30963545     DOI: 10.1111/epi.14723

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  The Association Between STX1B Polymorphisms and Treatment Response in Patients With Epilepsy.

Authors:  Shitao Wang; Liang Zhou; Chenglu He; Dan Wang; Xuemei Cai; Yanying Yu; Liling Chen; Di Lu; Ligong Bian; Sunbing Du; Qian Wu; Yanbing Han
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

2.  Changes in excitatory and inhibitory receptor expression and network activity during induction and establishment of epilepsy in the rat Reduced Intensity Status Epilepticus (RISE) model.

Authors:  Hope I Needs; Benjamin S Henley; Damiana Cavallo; Sonam Gurung; Tamara Modebadze; Gavin Woodhall; Jeremy M Henley
Journal:  Neuropharmacology       Date:  2019-07-26       Impact factor: 5.250

3.  PARVing the Way to Cap Translation for Seizure Control.

Authors:  Christina Gross
Journal:  Epilepsy Curr       Date:  2021-06-27       Impact factor: 7.500

Review 4.  Saporin from Saponaria officinalis as a Tool for Experimental Research, Modeling, and Therapy in Neuroscience.

Authors:  Alexey P Bolshakov; Mikhail Yu Stepanichev; Yulia V Dobryakova; Yulia S Spivak; Vladimir A Markevich
Journal:  Toxins (Basel)       Date:  2020-08-25       Impact factor: 4.546

5.  Loss of GABAergic Interneurons in Seizure-Induced Epileptogenesis-Two Decades Later and in a More Complex World.

Authors:  F Edward Dudek
Journal:  Epilepsy Curr       Date:  2020-10-15       Impact factor: 7.500

Review 6.  Saporin as a Commercial Reagent: Its Uses and Unexpected Impacts in the Biological Sciences-Tools from the Plant Kingdom.

Authors:  Leonardo R Ancheta; Patrick A Shramm; Raschel Bouajram; Denise Higgins; Douglas A Lappi
Journal:  Toxins (Basel)       Date:  2022-03-02       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.